Idogen AB Interim report Idogen AB Interim report
Board and Advisors | Ambulero
Trading Direkt analyserar bolagen på Spotlight 2019-06-19: Touchtech & Idogen - YouTube
Annual Report
Annual Report
Idogen handelsstoppad på Spotlight | Analysguiden - Analys, Börs, Bolagsfakta - användbart verktyg för investerare
Investors Home
Idogen%20Q1%20ENG - Idogen
Idogen's Historical Milestones - Idogen
Idogen AB Interim report Idogen AB Interim report
Idogen extends the project portfolio to projects in autoimmune diseases - Idogen
Crown Princess and Prince Daniel visited Idogen - Idogen
Idogen appoints Anders Karlsson as new CEO - Idogen
Biostock intervjuar Idogens VD Anders Karlsson om kvartalsrapport Q4 samt företrädesemissionen - IPO.se
Joakim Söderström - Idogen
Stories: EIC-funded company Idogen starts trading on Nasdaq First North Growth Market | EIC Community
Idogen's IDO 8 granted orphan drug designation in the USA - Idogen
Idogen AB (publ) Org nr
ANNUAL REPORT
Idogen's Historical Milestones - Idogen
Idogen files patent application for new tolerogenic cell therapy
